- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | ESC: MSD/Bayer's Verquvo disappoints in heart failure trial | ||
| Mo | IPO plan evaporates as private equity firm buys Stada | ||
| Mo | ESC: Real-world study gives Wegovy edge over Lilly rival | ||
| Mo | Sanofi breaks new ground for BTK drugs with ITP approval | ||
| Mo | ESC: 'Landmark' study backs AZ's baxdrostat for hypertension | ||
| Mo | Dose-at-home Leqembi for Alzheimer's cleared in US | ||
| Fr | Trump appoints HHS deputy O'Neill to lead CDC | ||
| Fr | UK adds chickenpox to childhood vaccination schedule | ||
| Do | Outlook blindsided as FDA blocks wet AMD drug once again | ||
| Do | Novo reels in Replicate for new cardiometabolic drugs | ||
| Do | Scoop: Lumos Labs has FDA nod for ADHD DtX Prismira | ||
| Do | Lilly pauses Mounjaro shipments to UK ahead of price hike | ||
| Do | Stada revives talk of an IPO - if conditions improve | ||
| Do | Lilly raises stakes in Novartis battle with Verzenio data | ||
| Do | CDC director refuses to step down after being fired | ||
| Mi | FDA ends emergency COVID authorisations, issues narrow approvals | ||
| Mi | Survey reveals 'trust gap' in the value of AI to cardiology | ||
| Mi | ESC: Study says GLP-1s treat heart failure AND cut emissions | ||
| Mi | Nykode changes tack after Roche exits partnership | ||
| Mi | Bayer files 'safer, greener' MRI contrast agent in US | ||
| 26.08. | Regeneron preps filings for myasthenia gravis drug | ||
| 26.08. | EVERSANA buys digital drug-price marketplace firm Waltz Health | ||
| 26.08. | Diabetics on Lilly's orforglipron shed 10.5% of their weight | ||
| 26.08. | Gilead poised to bring twice-yearly HIV PrEP to EU | ||
| 26.08. | Roche breaks ground on US manufacturing facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .